Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

María VelascoMaria Isabel GalánMaria Luisa CasasElia Pérez-FernándezDiana Martínez-PonceBeatriz González-PiñeiroVirgilio CastillaCarlos Guijarronull null

Published in: Open forum infectious diseases (2021)

Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.

Keyphrases

respiratory syndrome coronavirus
immune response
coronavirus disease
sars cov
dendritic cells
toll like receptor
electronic health record
hiv infected
big data